                                                                    EXHIBIT 99.3

[MERGE FILM LOGO GOES HERE]

[ACCUIMAGE LOGO GOES HERE]



                                                              JOINT NEWS RELEASE
                                                           FOR IMMEDIATE RELEASE
                         Contact: Beth Frost-Johnson, Merge eFilm, SVP-Marketing
                                    Richard Linden, Merge eFilm, President & CEO
                                                                  (414) 977-4000


                MERGE EFILM SIGNS DEFINITIVE AGREEMENT TO ACQUIRE
                           ACCUIMAGE DIAGNOSTICS CORP.
           ACQUISITION ACCELERATES ENTRY INTO ADVANCED VISUALIZATION;
                SETS NEW STANDARD FOR RIS/PACS SOFTWARE SOLUTIONS

         MILWAUKEE, WI AND SOUTH SAN FRANCISCO, CA NOVEMBER 24, 2004 - Merge
Technologies Incorporated (Nasdaq: MRGE), d.b.a. Merge eFilm, a leading global
healthcare software and services company, and AccuImage Diagnostics Corp.
(OTCBB: AIDP.OB), a leader in the development, marketing and support of software
for advanced visualization, analysis and management of medical imaging data from
medical imaging modalities, including state-of-the-art multi-slice CT and MRI,
today announced the signing of a definitive agreement by which Merge eFilm will
acquire AccuImage Diagnostic Corp. The all-cash transaction is valued at
approximately $6 million and is expected to close first quarter of 2005, subject
to satisfaction of customary closing conditions.

         "The acquisition of AccuImage is the next milestone in our strategy to
deliver comprehensive clinical and business workflow solutions to our
customers," said Richard Linden, Merge eFilm President and CEO. "The clinical
depth and capabilities of AccuImage will strengthen the Merge eFilm FUSION
RIS/PACS(TM) value proposition to both our direct and OEM/VAR customers. For
imaging centers, small to medium sized hospitals and clinics, the productivity
and financial advantages of a RIS/PACS solution with advanced visualization
capabilities will be significant."

                                     -MORE-

<PAGE>

         The AccuImage software portfolio, used by radiologists and specialty
physicians such as cardiologists, gastroenterologists, pulmonologists and
orthopedic surgeons, brings value to its customers by reducing the time
physicians need for reviewing and reporting cases, enhancing the interpretation
of studies, and providing additional sources of revenue. AccuImage's advanced
visualization tools released or in development include advanced 3D/4D
visualization, Calcium Scoring, Virtual Colonoscopy, CT Angiography, Lung Nodule
Detection, Subcutaneous Fat Measurement, and Image Stitching. Merge eFilm plans
to incorporate these tools into its FUSION RIS/PACS and FUSION PACS solutions,
providing the market with a unique RIS/PACS and PACS offering that includes
advanced visualization capabilities.

         "The acquisition of AccuImage makes a clear statement about Merge
eFilm's intent to be a leader in single-source software solutions for image and
information management," said Avi Faliks, PhD, and AccuImage's Chief Executive
Officer. "The Merge eFilm solutions are ideally suited for our advanced
visualization applications, and their customer base will bring these clinical
tools to an expanded market. Together, our solutions will accelerate our
customers' productivity and improve the care of the patients they serve."

         Commenting further, Linden said, "AccuImage will create accretive value
for our shareholders and an enhanced value proposition for our customers as we
take full advantage of the synergies between the two companies in 2005. These
advanced visualization tools, when combined with enterprise-wide accessibility
to images and information offered by our PACS and RIS/PACS solutions, reinforce
our strategy of delivering end-to-end clinical and business workflow solutions
that accelerate our customers' productivity."

         Both organizations will demonstrate their solutions at the Radiological
Society of North America (RSNA) Annual Conference next week in Chicago.

                                       ###

<PAGE>


ABOUT MERGE EFILM
Merge eFilm is a global healthcare software and services company focused on
accelerating the productivity of imaging centers, small- to medium-sized
hospitals and clinics with a suite of RIS/PACS products that more efficiently
streamline, integrate and distribute image and information workflow across the
healthcare enterprise. Since 1987, Merge eFilm has leveraged its healthcare
integration and connectivity experience to create workflow solutions that
improve our customers' productivity and enhance the quality of care they
provide. For additional information, visit WWW.MERGE-EFILM.COM

ABOUT ACCUIMAGE
AccuImage Diagnostics Corp. is a leader in the development, marketing and
support of software for visualization, analysis and management of medical
imaging data. AccuImage's software's primary function is to enhance physicians'
interpretation of data from medical imaging modalities, such as computer
tomography and magnetic resonance imaging through the application of three
dimensional computer graphics and image processing technologies. For additional
information, visit the AccuImage website at WWW.ACCUIMAGE.COM






Except for the historical information herein, the matters discussed in this news
release include forward-looking statements made pursuant to the safe harbor
provisions of Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements may involve a number of risks and uncertainties and
include, without limitation, statements concerning the proposed acquisition;
statements concerning the terms and timing of the acquisition; and statements
concerning management's plans, objectives, strategies and assessment of market
factors. Certain forward-looking statements used in this news release may
include the words: believes, intends, anticipates, expects, and similar
expressions . Forward-looking statements do not constitute guarantees of future
performance. Actual results could differ materially from those projected in the
forward-looking statements based on a number of factors, including, but not
limited to, risks in product and technology development, market acceptance of
new products and continuing product demand, the impact of competitive products
and pricing, ability to integrate acquisitions, unexpected outcomes to any
pending or future litigation, changing economic conditions, credit and payment
risks associated with end-user sales, dependence on major customers, dependence
on key personnel, and other risk factors detailed in filings with the Securities
and Exchange Commission. The Company undertakes no obligation to publicly
release the result of any revisions to these forward-looking statements that may
be made to reflect any future events or circumstances.


